Protecting workers and the surrounding environment from exposure to hazardous compounds poses an increasing challenge to pharmaceutical manufacturers as new and more potent active pharmaceutical ingredients (APIs) enter the processing pipeline, such as cytotoxic drugs to treat cancer.
Separation and purification processes potentially expose workers to harmful, biologically active, contaminating particulates and cataylysts filtered from the APIs. To help remedy the problem, Pall is introducing the GBK Containment System which provides the pharmaceutical industry with an all-in-one contained glove bag/housing system for filter change-out.
AdipoGen Life Sciences GLP-1, GIP and GCG receptor agonists
AdipoGen's range of GLP-1, GIP and GCG receptor agonists includes Liraglutide, Retatrutide,...
Integrated DNA Technologies xGen Hybridization and Wash v3 Kit
Integrated DNA Technologies (IDT) has unveiled its xGen Hybridization and Wash v3 Kit — a...
Cytek Tonbo Reagents
Cytek Tonbo Reagents are designed to enable high-quality research without breaking the budget....
